TRPM8 and prostate cancer: to overexpress or repress, that is the question-comment on "Effects of TRPM8 on proliferation and motility of prostate cancer PC-3 cells" by Yang ZH et al. in Asian Journal of Andrology.
Kulkarni
Prakash
P
James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of medicine, Baltimore, MD 21287, USA. pkulkar4@jmhi.edu
D017209:Apoptosis; D002453:Cell Cycle; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000502:physiology; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D004847:Epithelial Cells / Q000378:metabolism / Q000473:pathology; D051416:Focal Adhesion Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D050053:TRPM Cation Channels / Q000235:genetics* / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism
D004268:DNA-Binding Proteins; C501130:PURA protein, human; D050053:TRPM Cation Channels; C425966:TRPM8 protein, human; D014157:Transcription Factors; D051416:Focal Adhesion Protein-Tyrosine Kinases